Hutchmed China Ltd - ADR
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Hutchmed China Ltd - ADR
HUTCHMED (China) Ltd is an biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.
/ 
Frequently asked questions
To buy Hutchmed China Ltd - ADR stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Hutchmed China Ltd - ADR by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Hutchmed China Ltd - ADR is HCM:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Hutchmed China Ltd - ADR has its primary listing on NASDAQ. You can trade Hutchmed China Ltd - ADR with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Hutchmed China Ltd - ADR is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Hutchmed China Ltd - ADR as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Hutchmed China Ltd - ADR.